Ligand association rates to the inner-variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design |
| |
Authors: | Enrico L DiGiammarino John E Harlan Karl A Walter Uri S Ladror Rohinton P Edalji Charles W Hutchins Marc R Lake Amy J Greischar Junjian Liu Tariq Ghayur Clarissa G Jakob |
| |
Affiliation: | 1.Abbott Laboratories; Abbott Park, IL USA;2.Abbott Bioresearch Center; Worcester, MA USA |
| |
Abstract: | The DVD-Ig™ protein is a dual-specific immunoglobulin. Each of the two arms of the molecule contains two variable domains, an inner variable domain and an outer variable domain linked in tandem, each with binding specificity for different targets or epitopes. One area of on-going research involves determining how the proximity of the outer variable domain affects the binding of ligands to the inner variable domain. To explore this area, we prepared a series of DVD-Ig proteins with binding specificities toward TNFα and an alternate therapeutic target. Kinetic measurements of TNFα binding to this series of DVD-Ig proteins were used to probe the effects of variable domain position and linker design on ligand on- and off-rates. We found that affinities for TNFα are generally lower when binding to the inner domain than to the outer domain and that this loss of affinity is primarily due to reduced association rate. This effect could be mitigated, to some degree, by linker design. We show several linker sequences that mitigate inner domain affinity losses in this series of DVD-Ig proteins. Moreover, we show that single chain proteolytic cleavage between the inner and outer domains, or complete outer domain removal, can largely restore inner domain TNFα affinity to that approaching the reference antibody. Taken together, these results suggest that a loss of affinity for inner variable domains in this set of DVD-Ig proteins may be largely driven by simple steric hindrance effects and can be reduced by careful linker design.Key words: dual variable domain immunoglobulin, DVD-Ig, immunotherapy, variable domain, antibody engineering, dual-specific, linker |
| |
Keywords: | |
|
|